These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6977032

  • 41. In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease.
    La Corte R, Lo Mo Naco A, Locaputo A, Dolzani F, Trotta F.
    Autoimmunity; 2006 May; 39(3):249-53. PubMed ID: 16769659
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy.
    Furuya T, Hakoda M, Tsuchiya N, Kotake S, Ichikawa N, Nanke Y, Nakajima A, Takeuchi M, Nishinarita M, Kondo H, Kawasaki A, Kobayashi S, Mimori T, Tokunaga K, Kamatani N.
    J Rheumatol; 2004 Sep; 31(9):1768-74. PubMed ID: 15338498
    [Abstract] [Full Text] [Related]

  • 45. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
    Süsal C, Opelz G.
    Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Aberrant expression of major histocompatibility complex class II antigen in inflammatory myopathies].
    Kojima S, Takagi A.
    Rinsho Shinkeigaku; 1993 Jun; 33(6):612-9. PubMed ID: 8403680
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups.
    Miller FW, Love LA, Barbieri SA, Balow JE, Plotz PH.
    Clin Exp Immunol; 1990 Sep; 81(3):373-9. PubMed ID: 2168821
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Immunological aspects of polymyositis].
    Takayanagi T, Honda H.
    No To Shinkei; 1983 Jun; 35(6):525-33. PubMed ID: 6354219
    [No Abstract] [Full Text] [Related]

  • 52. [The principle antinuclear and anti-cytoplasmic antibodies in polymyositis and dermatomyositis. Study of 42 cases].
    Meyer O, Cremer-Legmann F, Haim T, Ryckewaert A.
    Presse Med; 1987 Feb 07; 16(4):155-8. PubMed ID: 2950445
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. HLA and antinuclear antibody incidence in asbestos workers.
    Matej H, Lange A, Garncarek D, Smolik R, Roszak E.
    Arch Immunol Ther Exp (Warsz); 1978 Feb 07; 26(1-6):201-5. PubMed ID: 312063
    [Abstract] [Full Text] [Related]

  • 55. SLE/myositis overlap: are the manifestations of SLE different in overlap disease?
    Dayal NA, Isenberg DA.
    Lupus; 2002 Feb 07; 11(5):293-8. PubMed ID: 12090563
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Genetics of the idiopathic inflammatory myopathies.
    Garlepp MJ.
    Curr Opin Rheumatol; 1996 Nov 07; 8(6):514-20. PubMed ID: 9018454
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. HLA antigens in adult polymyositis.
    Cumming WJ, Hudgson P, Wilcox CB.
    N Engl J Med; 1978 Dec 14; 299(24):1365. PubMed ID: 714109
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.